Insulin Analogues

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023

Untitled work

Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818

Intermittent High Glucose Enhances Apoptosis Related to Oxidative Stress in Human Umbilical Vein Endothelial Cells

Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 772

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739

Standards of Medical Care in Diabetes

(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 688

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Yki‐Järvinen, H., Dressler, A., Ziemen, M., & HOE 901/300s Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1130 · Cited by 573

Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review

DeWitt, D. E., & Hirsch, I. B. (2003) · JAMA · doi:10.1001/jama.289.17.2254 · Cited by 502

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483

Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the service

Tahrani, A. A., Digwood, S., Lee, C., & Moulik, P. K. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01190.x · Cited by 15

Traitement médicamenteux du diabète de type 2recommandation de bonne pratique

(2007) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)80038-3 · Cited by 20

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus - a systematic review and meta-analysis

Rys, P., Wojciechowski, P., Siejka, S. J., Małecki, P., Hak, Ł., & Malecki, M. T. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12337 · Cited by 14

Synthesis, cloning and expression of a novel pre-miniproinsulin analogue gene in Escherichia coli

Abolliel, A. A., & Hafez-Zedan, H. (2014) · Journal of Advanced Research · doi:10.1016/j.jare.2014.03.002 · Cited by 14

Comprender el concepto de inmunogenicidad

Valor, L., & de la Torre, I. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2012.09.002 · Cited by 14

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial ( GOLD‐5 )

Ólafsdóttir, A. F., Bolinder, J., Heise, T., Polonsky, W. H., Ekelund, M., Wijkman, M., Pivodic, A., Ahlén, E., Schwarcz, E., Nyström, T., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14257 · Cited by 13

The Impact of Technology on Current Diabetes Management

Garvey, K. C., & Wolfsdorf, J. I. (2015) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2015.04.005 · Cited by 14

Implementing an Intravenous Insulin Protocol in Your Practice: Practical Advice to Overcome Clinical, Administrative, and Financial Barriers

Kelly, J. L., Hirsch, I. B., & Furnary, A. P. (2006) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2006.06.004 · Cited by 13

Role of ultrafast-acting insulin analogues in the management of diabetes

Kruger, D. F., & Novak, L. M. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000261 · Cited by 17

Impact of therapeutic advances on hypoglycaemia in type 2 diabetes

Boyle, P. J., & Zrebiec, J. F. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.795 · Cited by 14

A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes

Meneilly, G. S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00639.x · Cited by 14

Technology and intensive management in youth with type 1 diabetes: State of the art

Wood, J., & Laffel, L. M. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0019-1 · Cited by 14

Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus

Kalirai, S., Stephenson, J. J., Perez‐Nieves, M., Grabner, M., Hadjiyianni, I., Geremakis, C. M., Pollom, R. D., Reed, B. L., & Fisher, L. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.10.001 · Cited by 13

Translating clinical guidelines into clinical practice: Role of the pharmacist in type 2 diabetes management

Drab, S. R. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08181 · Cited by 13

Practical Aspects and Considerations When Switching Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections

Meneghini, L., & Sparrow-Bodenmiller, J. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0184 · Cited by 13

Insulin Tactics in Type 2 Diabetes

Meah, F. A., & Juneja, R. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.021 · Cited by 13

Insulin-Related Knowledge Among Health Care Professionals at a Tertiary Hospital

Lee, M. K. S., Liu, Z., Quek, T. P. L., & Chew, D. E. K. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.3.187 · Cited by 13

Insulin in America: A Right or a Privilege?

Hirsch, I. B. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.3.130 · Cited by 13

Vitamin E induces regular structure and stability of human insulin, more intense than vitamin D3

Soleymani, H., Saboury, A. A., Moosavi‐Movahedi, A. A., Rahmani, F., Maleki, J., Yousefinejad, S., & Maghami, P. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.09.047 · Cited by 13

Drugs to Control Diabetes During Pregnancy

Feghali, M. N., Umans, J. G., & Catalano, P. M. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.005 · Cited by 13

Pharmacodynamic Evaluation: Diabetes Methodologies

Becker, R. H. A. (2010) · Springer eBooks · doi:10.1007/978-3-540-89891-7_33 · Cited by 13

Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH–IGF1–IGFBP axis in patients with type 1 diabetes

Ma, Z., Christiansen, J. S., Laursen, T., Lauritzen, T., & Frystyk, J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0258 · Cited by 13

Diabetes and Pregnancy

Thomas, A. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90988-2_15 · Cited by 12

Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report

Badik, J. R., Chen, J., Letvak, K., & So, T.-Y. (2016) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-21.1.85 · Cited by 12

Insulin Pump Therapy (Continuous Subcutaneous Insulin Infusion)

White, R. D. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.07.005 · Cited by 12

Comprehensive Management of Post-Transplant Diabetes Mellitus: From Intensive Care to Home Care

Goldberg, P. A. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.011 · Cited by 12

Management of Diabetes in Patients with Chronic Kidney Disease

Ahmed, Z., Simon, B. F., & Choudhury, D. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.2002 · Cited by 12

Cardiovascular Safety of Antihyperglycemic Agents: “Do Good or Do No Harm”

Manolis, A. S., Manolis, T. A., & Manolis, A. S. (2018) · Drugs · doi:10.1007/s40265-018-0985-4 · Cited by 12

People with type 1 diabetes using short acting analogue insulins are less dehydrated than those with using human soluble insulin prior to onset of diabetic ketoacidosis

Dhatariya, K. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.06.027 · Cited by 11

Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin

Kitabchi, A. E., & Gosmanov, A. R. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182449ff9 · Cited by 11

How Basal Insulin Analogs Have Changed Diabetes Care

Garg, S. K., & Moser, E. G. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0072 · Cited by 11

Diabetes Treatment, Part 3: Insulin and Incretins

Fowler, M. J. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.1.35 · Cited by 11

Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review

Hagenmeyer, E.-G., Koltermann, K. C., Dippel, F. W., & Schädlich, P. K. (2011) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-9-15 · Cited by 11

Proinsulin–Transferrin Fusion Protein Exhibits a Prolonged and Selective Effect on the Control of Hepatic Glucose Production in an Experimental Model of Type 1 Diabetes

Shao, J., Zaro, J. L., & Shen, W. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00168 · Cited by 11

Diabetes mellitus treatment—Related medical knowledge among health care providers

Shahla, L., Vasudev, R., Chitturi, C., Rodriguez, C., & Paul, N. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.010 · Cited by 11

Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System

Oh, J., Kim, J. H., & Park, H. (2018) · Annals of Laboratory Medicine · doi:10.3343/alm.2018.38.6.530 · Cited by 11

Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index)

Pérez-Maraver, M., Corchuelo, J. C., Lorenzo, A. B., Insa, R., Soler, J., & Montanya, E. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0320-y · Cited by 11

Diabetes mellitus – an overview

Sonia, T. A., & Sharma, C. P. (2014) · Elsevier eBooks · doi:10.1533/9781908818683.1 · Cited by 11

Endocrine pharmacology

Keegan, M. T. (2019) · Pharmacology and Physiology for Anesthesia · doi:10.1016/b978-0-323-48110-6.00036-3 · Cited by 11

Biphasic insulin aspart 70/30 three times a day in older patients with type 2 diabetes not achieving optimal glycemic control on a twice-daily regimen: A retrospective case series analysis from clinical practice

Tibaldi, J. T. (2007) · Advances in Therapy · doi:10.1007/bf02877782 · Cited by 11

Hypoglycemia in Diabetes

Cryer, P. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch33 · Cited by 11

Tipos de insulinoterapia

de la Fuente, J. S., Berná, V. G., Piquero, J. M. F., Zanuy, M. Á. V., & López-Coterilla, A. H. D. T. (2008) · Revista Clínica Española · doi:10.1157/13115203 · Cited by 12

PepSeA: Peptide Sequence Alignment and Visualization Tools to Enable Lead Optimization

Baylon, J. L., Ursu, O., Muždalo, A., Wassermann, A. M., Adams, G. L., Spale, M., Mejzlík, P., Gromek, A., Юрьевич, П. В., Hancharyk, D., et al. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01360 · Cited by 10

Composite efficacy parameters and predictors of hypoglycaemia in basal‐plus insulin therapy—a combined analysis of 713 type 2 diabetic patients

Seufert, J., Brath, H., Pscherer, S., Borck, A., Bramlage, P., & Siegmund, T. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12211 · Cited by 9

Engineering synthetically modified insulin for glucose-responsive diabetes therapy

Webber, M. J., Anderson, D. G., & Langer, R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1071187 · Cited by 10

Risk of cancer in patients receiving insulin glargine

Dawson, L. K., & Hamilton, L. A. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100109 · Cited by 10

Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia

Pedersen‐Bjergaard, U., Kristensen, P. L., Nørgaard, K., Perrild, H., Jensen, T. J., Thorsteinsson, B., Nikolajsen, A., & Tarnow, L. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1205006 · Cited by 10

Rapid‐acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes

Block, C. E. M. D., Cauwenberghe, J. V., Bochanen, N., & Dirinck, E. L. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14713 · Cited by 10

Facteurs déterminants du contrôle glycémique des patients diabétiques de type 2 suivis en première ligne

Abdelaziz, A. B., Soltane, I., Gaha, K., Thabet, H., Tlili, H., & Ghannem, H. (2006) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(06)76742-6 · Cited by 11

The Effect of Insulin Lispro on Glycemic Control in a Large Patient Cohort

Lind, M., Fahlén, M., Happich, M., Odén, A., & Eliasson, B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0297 · Cited by 10

Insulin therapy for type 2 diabetes

Meneghini, L. (2012) · Endocrine · doi:10.1007/s12020-012-9817-6 · Cited by 10

The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients

Duran, C., Tuncel, E., Ersoy, C., Ercan, I., Selimoğlu, H., Kiyici, S. K., Güçlü, M., Ertürk, E., & İmamoğlu, Ş. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345682 · Cited by 10

Update on Insulin Management in Type 2 Diabetes

Neumiller, J. J., Odegard, P. S., & Wysham, C. (2009) · Diabetes Spectrum · doi:10.2337/diaspect.22.2.85 · Cited by 10

The care of pregestational and gestational diabetes and drug metabolism considerations

Hedrington, M. S., & Davis, S. N. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1372423 · Cited by 11

Use of Insulin and Weight Gain: Optimizing Diabetes Nutrition Therapy

Daly, A. E. (2007) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.05.004 · Cited by 10

Glargine in pregnant patients with Type 1 diabetes

Tahrani, A. A., Varughese, G. I., Wilkins, J. D., Taylor, S., & Hanna, F. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02299.x · Cited by 10

INSULIN DETEMIR IN ROUTINE CLINICAL PRACTICE: A 26-WEEK FOLLOW-UP IN TYPE 1 DIABETIC PATIENTS FROM THE BELGIAN PREDICTIVE COHORT

Preumont, V., Buysschaert, M., Beukelaer, S. D., Mathieu, C., & on behalf of the Belgian PREDICTIVE Study Group (2009) · Acta Clinica Belgica · doi:10.1179/acb.2009.009 · Cited by 10

Diabetes Mellitus and Anesthesia

Tuttnauer, A., & Levin, P. D. (2006) · Anesthesiology Clinics of North America · doi:10.1016/j.atc.2006.05.006 · Cited by 10

Insulin and Oral Antidiabetic Agents

Mehanna, A. S. (2005) · American Journal of Pharmaceutical Education · doi:10.5688/aj690589 · Cited by 10

Diabetes in Pregnancy

Dornhorst, A., & Banerjee, A. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch53 · Cited by 10

The triggering pathway, the metabolic amplifying pathway, and cellular transduction in regulation of glucose-dependent biphasic insulin secretion

Bisht, S., & Singh, M. F. (2024) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2299920 · Cited by 10

Improving the stability of insulin through effective chemical modifications: A Comprehensive review

Kamelnia, R., Ahmadi‐hamedani, M., Darroudi, M., & Kamelnia, E. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124399 · Cited by 9

Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues: A Retrospective Population-Based Cohort Study

Cammarota, S., Falconio, L. M., Bruzzese, D., Catapano, A. L., Casula, M., Citarella, A., de Luca, L., Flacco, M. E., Manzoli, L., Masulli, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079762 · Cited by 9

Understanding the Immunogenicity Concept

Valor, L., & de la Torre, I. (2013) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2012.09.001 · Cited by 9

Hypoglycemia Reduction Strategies in the ICU

Braithwaite, S. S., Bavda, D. B., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0963-3 · Cited by 10

Half‐life prolongation of therapeutic proteins by conjugation to ATIII ‐binding pentasaccharides: a first‐in‐human study of C arbo C arrier® insulin

Miltenburg, A. M. M., Prohn, M., van Kuijk, J. H. M., Tiessen, R. G., de Kort, M., & Berg, R. J. W. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04460.x · Cited by 9

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

Farshchi, A., Aghili, R., Oskuee, M., Rashed, M., Noshad, S., Kebriaeezadeh, A., Kia, M., & Esteghamati, A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0116-8 · Cited by 9

Management of Diabetes in Children

Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 9

Insulin Granule-Loaded MicroPlates for Modulating Blood Glucose Levels in Type-1 Diabetes

Primavera, R., Bellotti, E., Mascolo, D. D., Francesco, M. D., Wang, J., Kevadiya, B. D., Pascale, A. D., Thakor, A. S., & Decuzzi, P. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c16768 · Cited by 11

Use of Serum and Plasma Glucose Measurements as a Benchmark for Improved Hospital-Wide Glycemic Control

Hoofnagle, A. N., Peterson, G. N., Kelly, J. L., Sayre, C. A., Chou, D., & Hirsch, I. B. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.556 · Cited by 9

Insulin therapy versus cell-based therapy for type 1 diabetes mellitus: what lies ahead?

Powers, A. C. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0971 · Cited by 9

Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes

Esposito, K., & Giugliano, D. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.648181 · Cited by 9

The treat-to-target A1C approach to control type 2 diabetes and prevent complications

White, R. D. (2007) · Advances in Therapy · doi:10.1007/bf02848777 · Cited by 9

Simulation and qualitative analysis of glucose variability, mean glucose, and hypoglycemia after subcutaneous insulin therapy for stress hyperglycemia

Strilka, R. J., Stull, M. C., Clemens, M. S., McCaver, S. C., & Armen, S. B. (2016) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-016-0029-2 · Cited by 9

Software-aided detection and structural characterization of cyclic peptide metabolites in biological matrix by high-resolution mass spectrometry

Yao, M., Cai, T., Duchoslav, E., Ma, L. M., Guo, X., & Zhu, M. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.05.012 · Cited by 9

Diabetes management in pregnancy

Chirayath, H. H. (2006) · Reviews in Gynaecological and Perinatal Practice · doi:10.1016/j.rigapp.2006.03.001 · Cited by 9

Use of short-acting insulin aspart in managing older people with diabetes

Sinclair, A. J. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s3142 · Cited by 9

The New Insulins

Crotty, S., & REYNOLDS, S. L. (2007) · Pediatric Emergency Care · doi:10.1097/pec.0b013e31816121ba · Cited by 9

Insulin and Insulin Treatment

Gough, S. C. L., & Narendran, P. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch27 · Cited by 9

Clinical application of the different cross-reactivities of anti-insulin antibodies to insulin lispro to evaluate endogenous insulin secretion

Yoshida, R., Ohkubo, K., Akehi, Y., Harada, S., Shinohara, K., Kawashima, H., Ono, J., & Matsunaga, A. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.10.062 · Cited by 8

Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus

Naggar, N. E., & Kalra, S. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0418-2 · Cited by 8

Restaging insulin therapy for patients with type 2 diabetes

Garber, A. J. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01136.x · Cited by 8

Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin

Ko, K. J., Tomor, V., Nathanson, B. H., Bouchard, J. R., Aagren, M., & Dubois, R. W. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.10.009 · Cited by 8

Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats

Anderson, J. D., Rondeau, D. A., & Hess, R. S. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15518 · Cited by 8

Insulin under the influence of light

Ursino, G., & Coppari, R. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20273 · Cited by 8

Screening for effective cell-penetrating peptides with minimal impact on epithelial cells and gut commensals in vitro

Gelli, H. P., Vazquez-Uribe, R., & Sommer, M. O. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1049324 · Cited by 8

Insulin Therapy and Hypoglycemia in Type 2 Diabetes Mellitus

Cryer, P. E., Irene, E., & Karl, M. M. (2007) · Insulin · doi:10.1016/s1557-0843(07)80041-8 · Cited by 8

Placental Transfer of the Insulin Analog Glargine in the Ex Vivo Perfused Placental Cotyledon Model

Kovo, M., Golan, A., Wainstein, J., Matas, Z., Haroutounian, S., & Hoffman, A. (2011) · Endocrine Research · doi:10.3109/07435800.2010.534752 · Cited by 8

Ensuring optimal insulin utilization in the hospital setting: Role of the pharmacist

Kelly, J. L. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100172 · Cited by 8

The role for insulin analogues in diabetes care

Thompson, R. J., Christie, D., & Hindmarsh, P. C. (2006) · Current Paediatrics · doi:10.1016/j.cupe.2005.12.011 · Cited by 8

A review of insulin and insulin regimens in type 2 diabetes

Joshi, S., & Joshi, P. (2009) · South African Family Practice · doi:10.1080/20786204.2009.10873820 · Cited by 8

Tight glycaemic control: clinical implementation of protocols

Nobels, F. R. E., Lecomte, P., Deprez, N., Pottelbergh, I. V., Crombrugge, P. V., & Foubert, L. A. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.09.001 · Cited by 8

Protected Graft Copolymer (PGC) Basal Formulation of Insulin as Potentially Safer Alternative to Lantus® (Insulin-Glargine): A Streptozotocin-Induced, Diabetic Sprague Dawley Rats Study

Reichstetter, S., Castillo, G. M., Lai, M., Nishimoto-Ashfield, A., Banerjee, A. A., Bogdanov, A. A., Jr., Lyubimov, A. V., & Bolotin, E. M. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0646-8 · Cited by 8

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes

Ruan, Y., Thabit, H., Leelarathna, L., Hartnell, S., Wilinska, M. E., Tauschmann, M., Dellweg, S., Benesch, C., Mader, J. K., Holzer, M., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12956 · Cited by 8

Recent research trend in cell and drug delivery system for type 1 diabetes treatment

Im, G., & Bhang, S. H. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0380-2 · Cited by 8

Effects of Glargine Insulin on Glycemic Control in Patients with Diabetes Mellitus Type II Undergoing Off-pump Coronary Artery Bypass Graft

Gandhi, H., Sarvaia, A., Malhotra, A., Acharya, H., Shah, K. H., & Rajavat, J. (2018) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_128_17 · Cited by 8

Qualitative analysis of subcutaneous Lispro and regular insulin injections for stress hyperglycemia: A pilot numerical study

Strilka, R. J., Armen, S. B., & INDECK, M. C. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.04.023 · Cited by 8

Insulines lentes aujourd’hui et demain : pour quels besoins non ou mal couverts ?

Monnier, L., & Colette, C. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70725-4 · Cited by 7

New Insulin Analogues and Perioperative Care of Patients with Type 1 Diabetes

Killen, J., Tonks, K. T. T., Greenfield, J. R., & Story, D. (2010) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1003800204 · Cited by 7

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

Aizen, D., Pasmanik‐Chor, M., Sarfstein, R., Laron, Z., Bruchim, I., & Werner, H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00105 · Cited by 7

Hypoglycemia with New Generation Basal Analog Insulins: A Descriptive Critical Review

Thrasher, M. A. J. R. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000576

Insulin analogues in the management of diabetes

Vázquez‐Carrera, M., & Silvestre, J. S. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.6.831318 · Cited by 37

The role of insulin analogues in the current treatment of diabetes mellitus

Mitrović, M., Pantelinac, P., Radosavljevic, J., Bajkin, I. A., & Todorovic-Djilas, L. (2006) · Medicinski pregled · doi:10.2298/mpns0612539m · Cited by 3

Role of New Insulin Analogs in the Management of Diabetes. A Clinical Review

Aziz, K. M. A. (2023) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000269

New Insulin Analogues and Routes of Delivery

Roach, P. J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847090-00003 · Cited by 31